Invention Grant
- Patent Title: Inhibitor of p38 MAP kinase
-
Application No.: US15253141Application Date: 2016-08-31
-
Publication No.: US09624196B2Publication Date: 2017-04-18
- Inventor: Alistair Ian Longshaw , Euan Alexander Fraser Fordyce , Stuart Thomas Onions , John King-Underwood , Jennifer Venable
- Applicant: RESPIVERT LTD , TOPIVERT PHARMA LTD.
- Applicant Address: GB High Wycombe GB London
- Assignee: RESPIVERT LTD.,TOPIVERT PHARMA LTD.
- Current Assignee: RESPIVERT LTD.,TOPIVERT PHARMA LTD.
- Current Assignee Address: GB High Wycombe GB London
- Agency: Knobbe, Martens Olson & Bear, LLP
- Main IPC: C07D401/12
- IPC: C07D401/12
Abstract:
A compound of formula (XV): wherein R1 represents an amino group, a protected amino group or nitro group; or a salt thereof. The compound is a p38 MAP kinase inhibitor. The compound and its pharmaceutically acceptable salts can be used for treatment of conditions, such as inflammatory diseases.
Public/Granted literature
- US20160368896A1 INHIBITOR OF p38 MAP KINASE Public/Granted day:2016-12-22
Information query
